Loading data
INVENasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 21.48 m USD | 26.63 m USD | 116.38 m USD | 112.92 m USD | 103.77 m USD |
| Cost of revenue | 20.18 m USD | 26.29 m USD | 74.22 m USD | 71.97 m USD | 66.7 m USD |
| Gross profit | 1.31 m USD | 340 k USD | 42.16 m USD | 40.94 m USD | 37.07 m USD |
| Research and development expense | 3.28 m USD | 3.89 m USD | 11.59 m USD | 9.92 m USD | 8.67 m USD |
| Operating profit | -22.15 m USD | -27.96 m USD | -5.06 m USD | -333 k USD | -1.35 m USD |
| Profit before tax | -18.27 m USD | -25.82 m USD | -5.33 m USD | -291 k USD | 1.65 m USD |
| Income tax expense | -268 k USD | 90 k USD | 164 k USD | 101 k USD | 28 k USD |
| Net income (reported basis) | -18 m USD | 74.82 m USD | -5,489 bn USD | -392 bn USD | 1,620 bn USD |
| Net income attributable to common shareholders | -18.83 m USD | 73.94 m USD | -6.76 m USD | -1.6 m USD | 472 k USD |
| Basic earnings per share | -0.79 USD/share | 3.14 USD/share | -0.29 USD/share | -0.07 USD/share | 0.02 USD/share |
| Diluted earnings per share | -0.79 USD/share | 3.14 USD/share | -0.29 USD/share | -0.07 USD/share | 0.02 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.